7.4 Implanted Ports

CRNI® Exam Study Guide Certified Registered Nurse Infusion

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application & Testing Windows 1.3 Scoring, Results & Recertification

2 Anatomy & Physiology for Infusion Practice

2.1 Vascular Anatomy & Physiology for Infusion 2.2 Body Positioning for Catheter Insertion & Removal 2.3 Vein Selection & Patient Assessment

3 Infection Prevention & Control

3.1 Infection Prevention Strategies & Standard Precautions 3.2 Chain of Infection in Infusion Practice 3.3 Bloodstream Infections & CLABSI Prevention 3.4 Phlebitis: Prevention, Grading & Management

4 Phlebotomy in Infusion Practice

4.1 Blood Sampling & Blood Culture Collection 4.2 Therapeutic Phlebotomy

5 Infusion Equipment & Technology

5.1 Solution Containers, Administration Sets & Filters 5.2 Add-on Devices, Administration Devices & Closed Systems 5.3 Vein Location Devices, Navigation Tools & Securement

6 Peripheral Venous Access Devices

6.1 Short & Long Peripheral Intravenous Catheters 6.2 Midline Catheters 6.3 Peripheral Device Selection Criteria

7 Central Venous Access Devices

7.1 Peripherally Inserted Central Catheters (PICC) 7.2 Non-tunneled Central Venous Catheters 7.3 Tunneled Central Venous Catheters 7.4 Implanted Ports

8 Alternate Access Routes & Device Maintenance

8.1 Subcutaneous Infusion Access 8.2 Intraosseous Access 8.3 Device Maintenance & Care Protocols

9 Special Populations in Infusion Therapy

9.1 Older Adults & Chronic Renal Conditions 9.2 Pediatrics, Immunocompromised, Oncology & Bariatrics

10 Device-Related Complications

10.1 Infiltration & Extravasation 10.2 Catheter Occlusion 10.3 Thrombosis, Air Embolism & Device-Related Systemic Events

11 Fluid & Electrolyte Balance

11.1 Body Composition & Fluid Balance 11.2 Fluid Volume Excess & Deficit 11.3 Electrolyte Disorders 11.4 Maintenance & Replacement Fluids

12 Parenteral Nutrition

12.1 Parenteral Nutrition: Solution Composition 12.2 PN Infectious, Metabolic & Mechanical Complications

13 Anti-infectives, Blood Products & Biologics

13.1 Anti-infective Infusion Therapy 13.2 Blood Products & Transfusion Therapy 13.3 Biologics & Immunologic Therapies

14 Antineoplastic, Cardiovascular & Pain Infusions

14.1 Antineoplastic Infusion Therapy 14.2 Cardiovascular Infusions 14.3 Pain Management Infusions

15 Therapy-Related Complications & Hazardous Drugs

15.1 Rate-Related Complications 15.2 Adverse Drug Reactions 15.3 Hazardous Drug Exposure & Waste Disposal

16 Professional Practice, Documentation & Quality

16.1 Assessment, Consent & Collaborative Care Planning 16.2 Documentation, Laws & Regulatory Agencies 16.3 Evidence-Based Practice & Performance Improvement

7.4 Implanted Ports

Key Takeaways Explain This Topic AI

Implanted ports consist of a subcutaneous reservoir connected to a central catheter; when deaccessed they have no external tubing, supporting body image and lower infection exposure between uses.

Access only with a non-coring Huber-type needle at a 90-degree approach into the septum; never use a standard hypodermic needle that cores the septum.

When deaccessed, ports typically require periodic flush/lock (often monthly per many protocols—follow policy/IFU); accessed needles have limited dwell times per product and policy.

Power ports allow power injection only when the port and needle are labeled compatible; confirm identification before CT contrast power injection.

Distinguish port pocket infection from catheter-related bloodstream infection; protect skin integrity over the reservoir and select ports for intermittent long-term therapy (e.g., many oncology regimens).

Last updated: August 2026

Implanted ports: hidden central access

An implanted port (totally implantable venous access device) places a reservoir (portal) under the skin, usually on the chest wall, connected to a catheter whose tip lies in the central venous system (lower SVC/cavoatrial region). When not in use, nothing protrudes—patients can bathe more freely (with healed incision) and avoid constant external lumen care, though they still need periodic maintenance flushes.

Quick Answer: Ports are CVADs with a subcutaneous septum reservoir . Access only with a non-coring (Huber) needle . Confirm blood return and flush before use. Deaccessed ports are commonly flushed about monthly (policy/IFU). Power ports need labeled port + compatible needle for power contrast. Watch skin integrity , pocket infection , and systemic CRBSI . Never access with a regular coring needle . Selection favors intermittent long-term therapy and body-image preferences.

Structure and how it works

• Part Role
• Portal body Rigid housing under skin
• Septum Self-sealing silicone accessed by non-coring needle
• Reservoir chamber Fluid space under septum
• Catheter connection Links portal to venous catheter
• Catheter tip Central location for therapy

Some systems are dual-lumen ports (two septa) for incompatible concurrent therapies. Arm ports exist but chest ports are classic exam images.

• Access technique: Huber / non-coring needles
• Why non-coring matters

A Huber needle has a deflected tip that slices the septum without removing a core of silicone. A standard hypodermic needle cores the septum, creating particulate debris and permanent leaks over repeated sticks— exam critical error .

• Access steps (principles)
• Verify order/indication; identify port type (including power capability markings/cards if available)
• Hand hygiene; sterile or aseptic field per policy for port access
• Skin antisepsis over portal with full dry time
• Locate portal edges; stabilize with non-dominant hand

Insert non-coring needle perpendicular ( 90° ) through skin into septum until it contacts the needle stop at the back of the port—do not rock excessively

• Aspirate for blood return ; flush with saline if patent; lock or begin therapy
• Secure needle with sterile dressing; use safety needles to prevent sharps injury

For continuous infusions, assess site frequently for swelling (needle dislodgement → extravasation risk, especially with vesicants)

No blood return: Troubleshoot (patient position, clot, needle not fully through septum, fibrin sheath). Do not assume safety for vesicants without establishing reliable access and return per protocol—extravasation into the pocket/tissue can be catastrophic.

Needle dwell

Non-coring needles left in place for intermittent or continuous therapy have maximum dwell times (commonly on the order of 7 days in many product/policy frameworks—always follow current IFU and organization standards). Change sooner if dressing integrity fails, contamination suspected, or pain/swelling occurs. When therapy pauses for extended periods, deaccess rather than leave a needle in without indication.

Maintenance when deaccessed

A healed, unused port still needs patency maintenance :

• Many protocols: flush and lock approximately every 4 weeks (monthly) when deaccessed
• Solutions: saline ± heparin lock per port type and policy (some valved systems differ)
• Each maintenance visit is still an aseptic access event—do not casual-stick without prep
• Document blood return, residual volume if required, and patient tolerance

Exam phrasing: “Port not used for six months, never flushed” → high risk of occlusion; maintenance schedules exist to prevent that.

• Power ports and imaging considerations
• Power-injectable ports

Power ports are engineered for high-pressure contrast injection. Before power injecting:

Confirm the implanted device is a power-rated port (patient wallet card, operative note, radiographic markers, palpation features per manufacturer—use two identifiers when possible)

• Use a power-rated non-coring needle and extension set rated for the PSI/flow
• Verify patency; follow maximum flow rates
• If identity is uncertain, do not power inject —use peripheral IV or non-power rates as appropriate
• MRI and other modalities (concepts)

Most modern ports are MRI conditional at specified field strengths when manufacturer conditions are met—not automatically “MRI unsafe forever,” but also not an excuse to ignore device labeling. Know that:

• Facility MRI screening must account for the implanted port and any other devices
• Radiopaque markers help identify port models on x-ray
• Always follow current manufacturer MRI conditions rather than blanket folklore
• Infection: pocket vs catheter vs systemic

Problem Local findings Implications

Port pocket infection Erythema, warmth, tenderness, fluctuance, drainage over reservoir; skin breakdown May require antibiotics, needle avoidance through infected tissue, surgical removal/pocket revision—serious

Exit of needle site infection Superficial changes at needle puncture while accessed Escalate care; may need deaccess

Catheter-related bloodstream infection Fever, chills, positive cultures, possible lack of local pocket signs Cultures, possible removal depending on organism and clinical status

Fibrin sheath / septic thrombophlebitis Dysfunction ± systemic infection Specialty management

Never access through cellulitic or abscessed skin over the port. Skin integrity education (avoid trauma, report thinning in cachectic oncology patients, rotate needle sites slightly within septum rules) protects the pocket.

Oncology vesicants: Confirm needle stability and blood return; monitor continuously for extravasation into the port pocket or surrounding tissue—swelling, burning, absence of blood return mid-infusion are emergencies.

Selection: ports in the CVAD decision tree

• Factor Port-favoring May favor PICC/tunneled instead
• Duration Months to years intermittent Weeks only
• Access pattern Intermittent (chemo cycles) Continuous multi-lumen daily complex home infusions
• Body image Prefers no external tube Accepts external line
• Needle aversion Poor candidate if severe needle phobia without support Prefers avoid needles

Infection history / neutropenia patterns Individualize with oncology/ID Sometimes externalized preferred for management strategy

Therapy chemistry Vesicants/chemo with confirmed central tip Same—ports are central when tip correct

Inpatient vs outpatient: Ports excel in ambulatory oncology. Acute multi-pressor ICU care still often uses non-tunneled multi-lumen CVCs even if a port exists—do not overload a single-lumen port for incompatible simultaneous drips without dual lumen or additional access.

Comparison table: all four central device classes

• Feature PICC Non-tunneled CVC Tunneled CVC Implanted port
• Insertion region Upper arm IJ/SC/femoral Tunnel to central vein Portal + catheter implant
• External when idle Yes Yes Yes No
• Typical dwell Weeks–months Days Months+ Months–years
• Special access tool Standard needleless hub Hub Hub Huber needle
• Big exam risk Malposition mid-clavicle Pneumothorax; femoral misuse Tunnel infection Regular needle access
• Scenario

A patient with intermittent chemotherapy every 3 weeks for 6 months prefers swimming and dislikes external tubes. A power-capable chest port is placed. Nursing plan: teach monthly deaccessed maintenance flushes, Huber-only access, report pocket redness, verify power status before CT, and monitor for blood return before each vesicant. Reject any suggestion to access with a standard IM needle “because it’s sharper.”

• High-yield exam traps
• Accessing a port with a regular (coring) needle
• Power-injecting without confirming power port + power needle
• Ignoring monthly (policy) maintenance when deaccessed
• Missing pocket infection while focusing only on fever
• Leaving a non-coring needle in indefinitely beyond dwell limits
• Assuming ports cannot extravasate vesicants if the needle dislodges into tissue

Choosing femoral non-tunneled “for convenience” when a long-term intermittent port pathway is already planned and acute central access is not required